Skip to main
NMTRQ
NMTRQ logo

9 Meters Biopharma Inc (NMTRQ)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy NMTRQ Stock

About 9 Meters Biopharma Inc (NMTRQ)

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume2.05K
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)-17.59x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

The 52-week high for NMTRQ stock is $0.00. The current NMTRQ stock price $undefined is 100.00% below its 52-week high

No, the NMTRQ stock does not pay dividends to its shareholders

How to buy NMTRQ stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NMTRQ stock

    Navigate to the Explore page. Then, type NMTRQ into the search bar. When you see NMTRQ stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NMTRQ stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy NMTRQ Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.